飛揚集團(01901.HK)預期中期淨虧7000萬元-8000萬元
格隆匯8月20日丨飛揚集團(01901.HK)公吿,預期集團於截至2021年6月30日止6個月將錄得虧損淨額人民幣7000萬元至人民幣8000萬元,而2020年同期的虧損淨額則約為人民幣1700萬元。
由於冠狀病毒爆發及所有出境旅行團持續暫停,(i)金融資產(包括貿易及其他應收款項)的信貸風險顯著增加導致貿易及其他應收款項預期減值增加;及(ii)機票及酒店住宿銷售、旅行團銷售及自由行產品銷售的邊際收入所產生的收益減少。因此,與2020年同期相比,集團截至2021年6月30日止6個月的虧損淨額有所增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.